Literature DB >> 3552823

Skeletal growth of fetuses from streptozotocin diabetic rat mothers: in vivo and in vitro studies.

E Heinze, U Vetter.   

Abstract

For largely unknown reasons severe or moderate diabetes of pregnant rats results in pronounced fetal growth retardation. Therefore, some skeletal growth parameters of fetal rats from streptozotocin diabetic mothers were studied in vivo and in vitro. Two days post conception rats were intravenously injected with 65 mg/kg body weight streptozotocin. On day 20 post conception 8 normal and 8 diabetic rat mothers received 5 mu Ci 3-H thymidine intraperitoneally. One day later the experiments were terminated. Fetal body weight and body length were significantly (p less than 0.05-0.001) reduced in the hyperglycaemic rats compared to normal rats, as was the thymidine incorporation into rib cartilage (p less than 0.02). In the cell culture colony formation from isolated chondrocytes of normal and hyperglycaemic fetuses was determined. Proinsulin, insulin (62.5-250 ng/ml), insulin-like growth factor I and II (6.25-25 ng/ml) significantly (p less than 0.05-0.001) augmented colony formation in a dose-dependent manner, with the somatomedins being 8 times more effective than proinsulin or insulin. Isolated chondrocytes from hyperglycaemic compared to normal fetuses formed significantly (p less than 0.05-0.001) fewer colonies in the basal state and in response to all 4 hormones. The results confirm the growth retardation of fetuses from diabetic rat mothers. A reduced responsiveness of chondrocytes from hyperglycaemic fetuses to various growth factors could be demonstrated as compared to cells from normal fetuses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552823     DOI: 10.1007/BF00274579

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  [Neonatal diabetes mellitus].

Authors:  H S Cole; H S Kim; C Zelson; C A Velasco
Journal:  Acta Diabetol Lat       Date:  1973 Mar-Apr

2.  Factors affecting the secretion of insulin and glucagon by the rat fetus.

Authors:  J R Girard; A Kervran; E Soufflet; R Assan
Journal:  Diabetes       Date:  1974-04       Impact factor: 9.461

3.  Skeletal growth in fetal rats. Effects of glucose and amino acids.

Authors:  E Heinze; R Brenner; C Nguyen-Thi; U Vetter; D Leupold; F Pohlandt
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

4.  Effects on rat fetuses of intrauterine injections of insulin.

Authors:  L Angervall; K Karlsson; A Martinson
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

5.  Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture.

Authors:  T W Sadler; L S Phillips; W Balkan; S Goldstein
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

6.  Diabetes in pregnancy. Skeletal malformations in the offspring of diabetic rats after intermittent withdrawal of insulin in early gestation.

Authors:  U J Eriksson; E Dahlström; C Hellerström
Journal:  Diabetes       Date:  1983-12       Impact factor: 9.461

7.  Fetal diabetes in rats and its effect on placental glycogen.

Authors:  V Barash; A Gutman; E Shafrir
Journal:  Diabetologia       Date:  1985-04       Impact factor: 10.122

8.  Increased thymidine incorporation into fetal rat cartilage in vitro in the presence of human somatomedin, epidermal growth factor and other growth factors.

Authors:  D J Hill; A T Holder; J Seid; M A Preece; S Tomlinson; R D Milner
Journal:  J Endocrinol       Date:  1983-03       Impact factor: 4.286

9.  Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction.

Authors:  W H Daughaday; K A Parker; S Borowsky; B Trivedi; M Kapadia
Journal:  Endocrinology       Date:  1982-02       Impact factor: 4.736

10.  Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy.

Authors:  U Eriksson; E Dahlström; K S Larsson; C Hellerström
Journal:  Diabetes       Date:  1982-01       Impact factor: 9.461

View more
  3 in total

1.  Regionally disturbed production of cartilage proteoglycans in malformed fetuses from diabetic rats.

Authors:  E Unger; U J Eriksson
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

2.  Insulin stimulates skeletal growth in vivo and in vitro--comparison with growth hormone in rats.

Authors:  E Heinze; U Vetter; K H Voigt
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

3.  Animal models for clinical and gestational diabetes: maternal and fetal outcomes.

Authors:  Ana Ci Kiss; Paula Ho Lima; Yuri K Sinzato; Mariana Takaku; Marisa A Takeno; Marilza Vc Rudge; Débora C Damasceno
Journal:  Diabetol Metab Syndr       Date:  2009-10-19       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.